Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany

Braun S, Mittendorf T, Greiner W, Dopatka J, von der Schulenburg JM (2007) .

Conference Abstract | Published | English

No fulltext has been uploaded

Author
; ; ; ;
Publishing Year
ISSN
PUB-ID

Cite this

Braun S, Mittendorf T, Greiner W, Dopatka J, von der Schulenburg JM. Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany.
Braun, S., Mittendorf, T., Greiner, W., Dopatka, J., & von der Schulenburg, J. M. (2007). Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany. Presented at the .
Braun, S., Mittendorf, T., Greiner, W., Dopatka, J., and von der Schulenburg, J. M. (2007).“Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany”.
Braun, S., et al., 2007. Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany.
S. Braun, et al., “Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany”, 2007.
Braun, S., Mittendorf, T., Greiner, W., Dopatka, J., von der Schulenburg, J.M.: Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany. (2007).
Braun, S., Mittendorf, T., Greiner, Wolfgang, Dopatka, J., and von der Schulenburg, J. M. “Cost-effectiveness of exemestane vs. tamoxifen in post-menopausal women with early breast cancer in Germany”., 2007.
This data publication is cited in the following publications:
This publication cites the following data publications:

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Search this title in

Google Scholar